Hillsdale Investment Management Inc. Eiger Bio Pharmaceuticals, Inc. Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$10.31 - $14.38 $131,968 - $184,064	-12,800 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$8.63 - $12.4 $110,464 - $158,720	12,800 New	12,800 $130,000
Q3 2018 Nov 09, 2018	SELL	$9.6 - $12.9 $59,520 - $79,980	-6,200 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$8.3 - $16.8 $51,460 - $104,160	6,200 New	6,200 $76,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $496M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.